FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to hepatology, and is intended for prediction of probability of chronic hepatitis C recurrence in patients after three months since beginning of antiviral therapy. For this purpose after three months since beginning of antiviral therapy in patient determined are biochemical parametres of blood: albumin in %; beta-lipoproteids in g/l, by which by means of certain nomogram probability of disease recurrence is determined.
EFFECT: method ensures increased accuracy of chronic hepatitis C outcome prediction.
2 ex, 1 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF CLINICAL OUTCOMES OF ANTIVIRAL THERAPY OF CHRONIC HEPATITIS B | 2011 |
|
RU2469327C1 |
METHOD OF PREVENTION OF CHRONIC VIRAL HEPATITIS TYPE C RECURRENT AFTER VIRUS REMISSION | 2007 |
|
RU2348412C1 |
METHOD FOR REVEALING OF CHOLESTEROSIS OF GALL BLADDER AT SICK OF CHRONIC VIRUS HEPATITIS C | 2007 |
|
RU2339947C1 |
METHOD FOR PREDICTION OF ANTIRETROVIRAL THERAPY OUTCOMES IN CHRONIC HEPATITIS B | 2014 |
|
RU2571493C2 |
METHOD FOR PREDICTION OF DEVELOPING METABOLIC SYNDROME IN PATIENTS WITH CHRONIC VIRAL HEPATITIS C | 2018 |
|
RU2684524C1 |
METHOD OF NON-INVASIVE DETERMINATION OF LIVER FIBROSIS STAGE IN PATIENTS WITH CHRONIC VIRAL HEPATITIS | 2008 |
|
RU2425633C2 |
METHOD OF FATTY LIVER DISEASE DIAGNOSTICS IN PATIENTS SUFFERING FROM CHRONIC VIRAL HEPATITIS C | 2006 |
|
RU2347226C2 |
METHOD FOR PREDICTION OF A STABLE VIROLOGIC RESPONSE TO THERAPY OF CHRONIC HEPATITIS C WITH PREPARATIONS OF DIRECT ANTIVIRAL ACTION IN THE PRESENCE OF LIPID DISTRESS SYNDROME | 2019 |
|
RU2710257C1 |
METHOD OF TREATING VIRAL HEPATITIS C | 2012 |
|
RU2496512C1 |
METHOD OF TREATMENT OF CHRONIC VIRAL HEPATITIS TYPE C | 2006 |
|
RU2345787C2 |
Authors
Dates
2011-01-10—Published
2009-04-20—Filed